Peptides Calculator Guides Stacks News Compare Glossary
TB-500: Benefits, Dosage, the BPC-157 Stack, and How to Get It in 2026
Medically reviewed by the Rite Aid Health Team · Last updated July 30, 2026
Research / not FDA approved Banned in sport
TB-500 is a synthetic fragment of thymosin beta-4 studied for cell movement, soft tissue repair, and blood vessel formation. Most supporting evidence comes from animal and laboratory research.
Get the Free Peptide Tracking Toolkit
TB-500 + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Get the free toolkit
Free download
Useful before or after you start
Before you start, compare the details that matter and build a focused question list. Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together. Separate your schedule from what actually happened, so important dates are easier to spot. Keep your private working copy on your own device.
Follow the text prompts to receive both downloads and your personal 20% off coupon.
Check your email
Confirm your email to receive the toolkit link.
Tell us where to send it
Free, no spam. We’ll text you about your toolkit and occasional offers. Unsubscribe anytime.
Mobile phone
Text me about my toolkit and occasional Rite Aid offers.
Msg & data rates may apply. STOP to opt out. HELP for help. Privacy & Terms.
Check your phone
Reply YES, then send your name and email. We’ll email the download link after confirmation.
What is TB-500?
TB-500 is a synthetic peptide based on a fragment of Thymosin Beta-4 (TB-4), a naturally occurring protein found in nearly all human and animal cells.
TB-4 plays a central role in building and recycling actin, one of the structural proteins cells use to move and rebuild tissue. TB-500 reproduces the active region of that protein in a more stable synthetic form. It does not occur in this isolated form in nature.
Benefits and uses
What the research shows — most of it in animal models, which is the honest framing for TB-500:
Soft-tissue and muscle regeneration. The most-studied effect. TB-500 promotes cell migration and the actin regulation that lets tissue rebuild, which speeds recovery in animal injury models. Blood-vessel formation. It supports angiogenesis — the growth of new blood vessels into healing tissue — improving the blood supply an injury needs to repair. Inflammation modulation. TB-500 dampens inflammatory signaling, part of why it is used during recovery. Systemic reach. Because Thymosin Beta-4 is present throughout the body, TB-500 is studied for whole-body cell migration and regeneration rather than purely local repair.
The gap between the volume of anecdote and the volume of human evidence is real. TB-500 has a following built on animal research and athlete reports; rigorous human clinical trials are limited. State that plainly rather than overselling.
How it works
TB-500 works largely by regulating actin, the protein that drives cell movement. By promoting cell migration to the site of an injury, it helps the cells that rebuild tissue reach where they are needed.
It also supports angiogenesis and modulates inflammation. The combined effect is faster, better-supplied tissue repair across muscle, tendon, and other soft tissue.
Dosage and administration
Typical protocols in the literature and clinical practice use subcutaneous injection, often run in a loading-then-maintenance pattern: a higher loading dose over the first 4–6 weeks, then a lower maintenance dose.
These are not official dosing guidelines — there is no FDA-approved TB-500 product — and dosing should be set by the prescribing provider.
Reconstitution (mixing the lyophilized powder with bacteriostatic water) and drawing the right volume on an insulin syringe is where most people make errors.
For a peptide your clinician prescribed and an appropriate pharmacy prepared, use the peptide dosage calculator to convert the prescribed target dose into syringe units for your vial size.
Side effects and safety
TB-500 has shown a favorable safety profile in animal studies. Reported effects in human use are generally mild — injection-site reactions, fatigue, head rush or lightheadedness shortly after a dose.
The honest caveat: long-term human safety data does not exist. Anyone using TB-500 should monitor liver enzymes and kidney function and work with a provider.
Legal status and how to get it in 2026
The FDA removed TB-500 from its Section 503A Category 2 list in April 2026.
On July 23 and 24, an FDA advisory committee recommended adding it to the Section 503A Bulks List. The committee considered wound healing.
The vote was advisory. It was not drug approval, and the FDA has not made a final decision. Current access rules remain unchanged.
Products sold online for research use are not approved for human use. Their identity, strength, and quality may be uncertain.
Read the FDA meeting materials.
Get the Free Peptide Tracking Toolkit
TB-500 + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Get the free toolkit
Free download
Useful before or after you start
Before you start, compare the details that matter and build a focused question list. Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together. Separate your schedule from what actually happened, so important dates are easier to spot. Keep your private working copy on your own device.
Follow the text prompts to receive both downloads and your personal 20% off coupon.
Check your email
Confirm your email to receive the toolkit link.
Tell us where to send it
Free, no spam. We’ll text you about your toolkit and occasional offers. Unsubscribe anytime.
Mobile phone
Text me about my toolkit and occasional Rite Aid offers.
Msg & data rates may apply. STOP to opt out. HELP for help. Privacy & Terms.
Check your phone
Reply YES, then send your name and email. We’ll email the download link after confirmation.
TB-500 vs BPC-157 — and why they're stacked
TB-500 and BPC-157 are the most common recovery pairing. The two do different jobs: BPC-157 drives local repair and angiogenesis at the injury site, while TB-500 supports systemic cell migration and broader soft-tissue regeneration.
Run together, they cover both the local and the whole-body side of healing, which is why they are run as a cycle rather than alone.
For the broader recovery protocol, compare TB-500 with other healing and recovery peptides, and see KPV for the anti-inflammatory addition.
Blood work to track TB-500
TB-500 doesn't have a single direct biomarker, so tracking focuses on the inflammation it's meant to reduce and on safety:
hs-CRP — a sensitive inflammation marker; useful to see whether systemic inflammation is trending down. Comprehensive metabolic profile — liver enzymes and kidney function, the safety baseline for any peptide cycle.
Test before you start and again at 4–6 weeks.
Baseline tests before a peptide cycle
Check safety and response markers before starting. These tests help establish a baseline for liver, kidney, glucose, hormone, and recovery tracking.
References
PubMed: Thymosin beta-4 and wound healing literature PubMed: Thymosin beta-4 and tissue repair reviews FDA: Bulk drug substances used in compounding under Section 503A
Banned in competitive sport. This peptide is prohibited by the World Anti-Doping Agency (WADA), and athletes subject to drug testing can face sanctions for using it. Check current WADA and league rules before considering it.
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.
FAQ
Most commonly for soft-tissue and muscle injury recovery — promoting cell migration, regeneration, and blood-vessel formation. The strongest evidence is in animal research; human clinical data is limited.
An FDA advisory committee recommended TB-500 for the Section 503A Bulks List in July 2026. The vote was not drug approval, and the FDA has not made a final decision. Research-only products are not approved for human use.
Protocols commonly use subcutaneous injection in a loading-then-maintenance pattern over 4–6 week blocks, but there is no FDA-approved product or official dosing. Dosing should be set by a prescribing provider.
Reported effects are generally mild — injection-site reactions, fatigue, lightheadedness after a dose. Long-term human safety data does not exist, which is the main caution.
Yes — it's the standard recovery pairing. BPC-157 drives local repair and angiogenesis at the injury site; TB-500 supports systemic cell migration and broader tissue regeneration.
Protocols typically run in 4–6 week blocks. For an acute injury, users often report effects within the first cycle, and inflammatory markers like hs-CRP may shift within the first few weeks.